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ABSTRACT The interaction of thyrotropin-releasing hor-
mone (TRH) and its physiological metabolite TRH-OH with
Na+ channels was studied in enzymatically dissociated guinea
pig septal neurons by using the whole-cell variant of the
patch-clamp technique. In about 60% of the cells tested, the
neuropeptides at concentrations between 0.01 and 2.5 ,uM
produced a dose-dependent reversible attenuation of Na+
currents. With 2 ,uM TRH-OH, peak Na+ current amplitude
was reduced by 20-50% (27 ± 8%, mean ± SD; n = 16),
whereas at the same concentration TRH was approximately
half as effective as TRH-OH. In the presence of the tripeptides,
the voltage-dependent parameters of the Na+ current were
unaltered. TRH-induced reduction of Na+ current amplitude
was transient and recovered almost completely during main-
tained exposure to the peptides. In addition, the response to
either TRH-OH or TRH decreased with repeated treatment.
Our results demonstrate that neuronal Na+ channels can be
modulated by naturally occurring neuropeptides.
It is well established that voltage-gated neuronal Ca2" and K+
channels can be modulated by transmitters and neuropep-
tides (for reviews, see refs. 1 and 2), but it is generally
believed that Na+ channels are unaffected by physiological
metabolites and ligands. A common view is that Ca2' and K+
channels are directly implicated in the subtle mechanisms
underlying neuronal integration and responses to changes in
the cell environment, whereas Na+ channels are specialized
in the generation of the fast transmembrane current required
for electrical signaling and thus are less susceptible to mod-
ulation (see, however, ref. 3). In this report we show unmis-
takable evidence indicating that thyrotropin-releasing hor-
mone (TRH; pyroGlu-His-Pro-NH2) and, with more potency,
its physiological derivative TRH-OH (pyroGlu-His-Pro-OH)
reversibly inhibit Na+ channel activity in freshly dissociated
guinea pig septal neurons. It has been claimed that TRH,
besides its role in pituitary control, has numerous functions
in the mammalian central nervous system (4, 5). The hor-
mone and its metabolites are broadly distributed in the brain,
and the septal region is particularly rich in TRH-like immuno-
reactivity and contains saturable TRH receptors (5-7). Ex-
trahypothalamic TRH is very unstable and after being re-
leased by nerve terminals, is rapidly converted into new
products. Therefore, TRH is considered to be a "prohor-
mone" or "precursor" of peptides with their own biological
activity (8, 9). TRH-OH, produced after cleavage of the
C-terminal amide group by a specific proline endopeptidase,
is one of the most stable derivatives of TRH and is found at
high levels in numerous brain regions (8, 9). It was known that
TRH has several neuropharmacological effects and that it can
modify the electrical activity of brain cells (10-12), but the
modulatory action of Na' channels of both the hormone and
the metabolite was totally unexpected. Thus, our findings
discover a novel aspect in the physiology of Na' channels
and in addition provide significant clues regarding the action
at the cellular level of brain TRH and its biotransformation
products.
METHODS
Septal cells were obtained from slices 300-400 Am thick of
the guinea pig brain. The procedure followed for slicing was
the same as described (13). For cell dissociation, six slices of
the septal nucleus, isolated from the rest of the brain with fine
scissors, were placed in a vial containing 3 ml of Earle
solution (Flow Laboratories) with 0.2 mg of trypsin type IX
and 0.05 mg of DNase type II (Sigma) per ml. This solution
was continuously bubbled with 95% 02/5% CO2 and incu-
bated for 20 min at 370C. The tissue was washed twice with
solution containing 1 mg of albumin per ml to remove the
enzymes. Cells were mechanically dispersed with fire-
polished Pasteur pipettes of various sizes, centrifuged, and
resuspended in minimal Essential Medium (Flow Laborato-
ries) supplemented with 1% glutamine, 10% (vol/vol) fetal
bovine serum, and antibiotics. Cells were plated on fragments
of glass coverslips treated with poly(L-lysine) and maintained
in a CO2 incubator until use (2-10 hr after plating). At this
stage the cells had an almost spherical shape and no appre-
ciable processes under the light microscope.
During the experiments, a coverslip was transferred to a
chamber of 0.2 ml with continuous flow of solution that could
be changed in '15 s. Ionic currents were recorded in the
"whole-cell" configuration of the patch-clamp technique
(14). The general procedures and the setup used were the
same as described (15). We used a patch-clamp amplifier built
by following the design by Sigworth (16) with the modifica-
tions described by Matteson and Armstrong (17). A fast and
uniform control of the membrane potential was favored by
the use of low-resistance electrodes (0.8-2 Mfl), a feedback
resistance of only 100 Mft in the current-to-voltage con-
verter, and electronic compensation of series resistance. The
amplifier was interfaced to an IBM-PC/AT computer, which
was used for generation of command voltage pulses and for
acquisition, display, and analysis of the data (18). Linear
ionic and capacity currents were subtracted by using the P/2
procedure (19). The composition of the recording solutions is
indicated in the figure legends. High-purity peptides were
obtained from Sigma, dissolved in distilled water, and kept at
-200C. Fresh aliquots of neuropeptides were used in each
experiment. Experiments were done at room temperature
(20-250C).
Abbreviations: TRH, thyrotropin-releasing hormone; TTX, tetrodo-
toxin.
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RESULTS
TRH-OH and TRH Reversibly Reduce Na' Channel Activ-
ity. Freshly dissociated septal neurons subjected to voltage
clamp can generate voltage-dependent Na+, Ca2", and K+
currents. The characteristics of these currents are described
elsewhere (20). Fig. 1 summarizes the effect of TRH-OH on
the Na+ and K+ currents in a neuron dialyzed with high K+
and bathed in the standard 130 mM Na+ solution. Inward
currents with a time course typical of Na+ currents could be
recorded during voltage steps to -20 (Fig. 1A) or 0 (Fig. 1B)
mV (control traces). With a larger depolarization (Fig. 1C),
the inward current was followed by a slower outward K+
current. Exposure of the cell to a test external solution of the
same ionic composition but with 2.5 ,uM TRH-OH added
produced a decrease in the amplitude of the Na+ current by
about 50%, leaving the outward current unaltered (TRH-OH
trace). The effect of the tripeptide was almost perfectly
reversible as illustrated by the recovery traces. Small differ-
ences seen between control and recovery currents in some
experiments are likely because of a 5- to 10-mV shift toward
negative potentials in the current-voltage curve of Na+
channels in dialyzed cells (21). Peak inward and outward
current amplitude as a function of the pulse membrane
potential is plotted in Fig. 1D before and during the applica-
tion of TRH-OH. Thus, in septal neurons TRH-OH can
attenuate Na+ current without affecting the K+ current.
Similar qualitative effects were observed with TRH. In all
TRH-sensitive neurons (n = 71), the inhibition of the Na+
current appeared in 20-30 s after introduction of either
A
TRH-OH or TRH, and the recovery was complete in about
60 s after switching to the control solution. Ca2+ channels,
although not studied in detail, seemed to be unresponsive to
the tripeptides. There are, however, septal cells where the
K+ currents were also modified by both TRH and TRH-OH
(20). The present report focuses on the modulation of Na+
channels.
The interaction of the neuropeptides with Na' channels
was further studied in neurons where the internal solution
(inside the pipette and the cell) contained Cs+ instead of K+
to block K+ channels. Fig. 2A shows recordings of isolated
TRH-OH Na+ currents during depolarizations to 0 mV. In
this experiment 2 ,gM TRH-OH diminished the peak current
amplitude by about 30%. After TRH-OH wash-out, the
addition of 1 gM tetrodotoxin (TTX) to the same cell abol-
ished the inward current, which indicates that in this respect
Na+ channels exposed to the tripeptide behaved normally.
Inhibition of Na+ current by the peptides is dose dependent
and, in Fig. 2 B and C, the effect of lower concentrations of
TRH-OH (0.1 ,uM in B and 0.01 tkM in C) is shown for
comparison. Na+ current amplitude was reduced with com-
plete reversibility by 20% and 10%, respectively. We have
tested so far the effect of TRH, TRH-OH, or both (at
concentrations between 0.01 and 2.5 ,uM) in more than 100
septal neurons, and in about 60% of them, a dose-dependent
attenuation of the Na' current between 10% and 50% was
observed. At a concentration of 2 ,uM, TRH-OH decreased
current amplitude by 27 + 8% (mean + SD; n = 16). With 0.1
and 0.01 gM TRH-OH, the average reduction in the current
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FIG. 1. Effect of TRH-OH on the Na+ and K+ currents of septal neurons. (A-C) Currents recorded during 9-ms (A and B) and 20-ms (C)
voltage steps to the indicated membrane potentials from a holding potential of -80 mV. Recordings were obtained with (TRH-OH trace) and
without (control and recovery traces) 2.5 ,uM TRH-OH added to the external solution. (D) Current-voltage relations of peak outward and inward
currents measured in the absence (e) and presence (in) of TRH-OH. The external solution was 130 mM NaCI/2.7 mM KCI/10 mM CaCl2/1 mM
MgCI2/10 mM Hepes, pH 7.4. The internal solution was 80 mM potassium glutamate/20 mM KF/30 mM KCI/2 mM MgCl2/3 mM Mg-ATP/10
mM EGTA/10 mM Hepes, pH 7.3.
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FIG. 2. Dose-dependent inhibition of isolated Na' currents by TRH-OH. Recordings were obtained in three different cells before (control
trace), during (TRH-OH trace), and after (recovery trace) exposure to 2 IAM (A), 0.1 ,uM (B), and 0.01 j.M (C) TRH-OH. In A, after wash-out
of TRH-OH, the current was completely blocked by 1 juM TTX. Note that in C there is a slow Ca2+ component in the inward current that is
not affected by the tripeptide. The holding potential was -80 mV, and the test potentials were 0 mV (A), -20 mV (B), and -10 mV (C). Pulse
duration was 7 Ms. The external solution was 130 mM NaCl/2.7 mM KCl/2.5 mM CaCl2/1 mM MgCI2/10 mM Hepes. The internal solution
was 70 mM CsCI/20 mM CsF/40 mM NaCl/4 mM Mg-ATP/5 mM Hepes/5 mM EGTA.
amplitude was 16% (n = 5) and 9% (n = 10) respectively. At
the same concentrations, TRH was almost half as effective as
TRH-OH.
These results indicate that TTX-sensitive Na+ currents
with normal activation and inactivation kinetics are inhibited
by TRH-OH and, less effectively, by TRH. However, the
effect is specific to some cells, which suggests that the
tripeptides do not directly block the channels but that a
A
different mechanism, perhaps involving a receptor and some
intracellular mediator, is required.
TRH-OH Does Not Alter the Voltage-Dependent Parameters
of Na+ Currents. Although Fig. 1D already shows that the
Na+ current-voltage relation was not displaced by TRH-OH,
we further examined the possibility that this peptide could
shift the voltage-dependent parameters ofNa+ currents. This
is also of importance because it has been recently shown that
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FIG. 3. Effect of TRH-OH on the voltage-dependent parameters of Na+ currents. (A) Superimposed sweeps of Na+ currents elicited by
depolarization to the indicated membrane potentials with and without 2 ,uM TRH-OH added to the external solution. Current sweeps recorded
during exposure to the peptide are scaled by a factor of 1.3. (B) Voltage dependence of steady-state inactivation (H oo) and of the peak Na+
conductance (GNa) in the control solution (0) and in the presence of 2 gM TRH-OH (i). The continuous lines were fitted by eye. H co was
determined by applying 50-ms depolarizing prepulses of variable amplitude (abscissa) followed by a pulse to 0 mV. The normalized peak current
amplitude during the pulse is represented on the ordinate. Normalized GNa (ordinate) was calculated by the formula GNa = Imax/(VM - ENa).
Imax is the peak current elicited by steps to different membrane potentials (VM, abscissa). ENa was +32 mV. Solutions for A and B are as in
Fig. 2. (C Upper) Na+ currents recorded during 700-,us steps to 0 mV from -80 mV in the control solution and during application of 2 ILM
TRH-OH. Step duration is indicated by the arrows. (C Lower) Superposition of the two traces after scaling the TRH-OH sweep by a factor of
1.24. The external solution was 80 mM Na/70 mM Trizma, pH 7.4/2.7 mM KCI/2.5 mM CaCl2/1 mM MgCl2. The internal solution was 100
mM CsCl/30 mM CsF/10 mM Hepes/5 mM EGTA/4 mM Mg-ATP.
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isoproterenol (although only partially reversible) shifts
steady-state inactivation of cardiac Na' channels toward
negative voltages (3). Fig. 3 summarizes the effect of
TRH-OH on activation, inactivation, and closing of septal
Na' channels. In Fig. 3A, inward and outward Na' currents
recorded at the indicated membrane potentials with and
without external addition of TRH-OH are shown. The traces
in TRH-OH are scaled by a factor of 1.3 to match the
amplitude of the control current. The two superimposed
current sweeps, recorded with a time interval of -80 s, are
undistinguishable, demonstrating that although TRH-OH re-
duced current amplitude by about 30%, activation and inac-
tivation time courses were unchanged. In this experiment we
used an internal solution with 40 mM Na' to obtain a
well-defined reversal potential (ENa); before and during ap-
plication of TRH-OH, ENa was +32 mV. Fig. 3B shows the
voltage-dependence of steady-state inactivation (H mo) and of
the peak Na+ conductance (GNa) with values measured in the
absence and presence of TRH-OH. The two sets of normal-
ized values are superimposable, indicating that these param-
eters were also unaltered by TRH-OH. The effect of the
peptide on Na+ deactivation is shown in Fig. 3C. The top
traces are Na+ currents elicited by a brief voltage step to 0
mV, indicated by the arrows, before and during exposure to
TRH-OH. Repolarization occurs when the pulse current is
maximal and is followed by tail currents that reflect the
progressive closure of the channels open during the pulse. At
the bottom it is clearly illustrated that scaling the TRH-OH
sweep by a factor of 1.24 perfectly overlaps the control
current.
These results indicate that TRH-OH does not shift the
voltage-dependence of Na+ channels and that those that
remain functional during exposure to the neuropeptide be-
have normally. Thus, the reduction of the Na+ current
xE
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amplitude is most likely due to a decrease of either single-
channel conductance or the open probability of the channels.
Maintained Exposure to TRH Produces a Transient Atten-
uation of Na' Current Amplitude. Although in most experi-
ments cells were bathed by the test solution (with TRH or
TRH-OH) for only 30-60 s, we studied in a few neurons the
effect of a more permanent exposure to the tripeptides. Fig.
4A is a plot of the normalized peak Na' current amplitude
(ordinate) versus the time after obtaining the whole-cell
configuration. The cell was repeatedly exposed to TRH-OH,
and switching to a new solution is indicated by vertical
arrows. The four sweeps drawn in Fig. 4B are indicated by
their respective number. TRH-OH produced in 30-40 s a
maximal decrease of Na+ current amplitude of 23% (sweep
2). However, this effect was transient, and in the course of
the following 2 min, current amplitude increased to almost
90% of the initial value. Current amplitude completely re-
covered after reintroduction of the control solution (compare
sweeps 1 and 3). A second exposure to the peptide produced
a maximal decrease in the current amplitude of only 10%,
which was also transient. Similar qualitative results were
seen either with TRH or TRH-OH at concentrations as low
as 0.1 ,uM in all neurons studied with this experimental
protocol (n = 9). These observations reveal that the effect of
the tripeptides on Na+ channels is transient and that there is
a loss of responsiveness during repeated exposure to TRH or
TRH-OH.
DISCUSSION
In this report there are two major findings: (i) Na+ channels
can be modulated by ligands normally occurring in the
mammalian brain, and (ii) extrahypothalamic TRH and its
physiological derivative TRH-OH modify membrane ionic
permeability in central nervous system neurons with com-
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FIG. 4. Effect of maintained and repeated exposure to 2.5 ,uM TRH-OH. (A) Normalized peak Na+ current amplitude (ordinate) recorded
during 7-ms steps to 0 mV from -80 mV at different times in min after the onset of the whole-cell recording mode. Measurements are represented
by dots, and the vertical arrows indicate the switching to a new solution. ln B there are four selected current sweeps identified by their respective
number in A. Solutions were as in Fig. 3C.
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plete reversibility. There are previous data indicating that in
the gM range TRH can produce enhancement or depression
of neuronal excitability (11, 22-24). TRH-induced depolar-
ization is compatible with inhibition of voltage-dependent K+
channels, an effect demonstrated in clonal adenohypophy-
seal cells (25) and also observed by us in preliminary exper-
iments (20). On the contrary, the depression of neuronal
excitability could be explained by the attenuation of the Na+
current reported here. Inhibition of Na+ channel activity is
expected to produce an increase in the firing threshold and a
decrease in the rate of rise of action potentials. On physio-
logical grounds it can be speculated that these effects would
favor discrimination of large synaptic inputs and a more
maintained Ca2+ entry during longer-lasting action poten-
tials.
The effect of TRH and TRH-OH was selective to some
cells, and they did not seem to directly block the channels.
This implies that the target neurons must specifically express,
with the appropriate distribution, receptors for the tripep-
tides and the deamidating enzyme that synthetizes TRH-OH.
The concentrations ofTRH and TRH-OH that attenuate Na+
currents are within the range of the dissociation constant of
low- and high-affinity receptors for TRH-like peptides de-
scribed in neuronal bodies of the septum and other parts of
the brain (7, 8). The regional distribution of proline endopep-
tidase is not well studied, but high enzymatic activity is found
in the soluble fraction of homogenated cerebral tissue (8, 9).
Interestingly, the effect ofTRH and TRH-OH was transient,
and their potency decreased with repeated treatment. In
pituitary cells subjected to voltage clamp it is known that
TRH induces a transient release of Ca2+ from internal stores
(26) with a time course similar to the recovery ofNa' current
amplitude reported here during maintained exposure to the
neuropeptides. TRH-induced Ca21 mobilization also de-
creases with repetitive exposure to the stimulus, presumably
because intracellular mediators are being exhausted (26).
Inhibition of Na+ channels by TRH may also involve an
intracellular mediator that could induce phosphorylation of
the channel protein. Several phosphorylation sites, missing in
the electroplax Na' channel, are known to exist in the a
subunit of neuronal Na+ channels (27). In conclusion, TRH
and its biologically active metabolite TRH-OH regulate Na+
channels in septal neurons; the effect of the peptides is
selective and reversible. This phenomenon, which confers a
new perspective upon the physiology of Na+ channels, may
be also caused by other neuropeptides and may occur in other
central neurons as well. The molecular mechanism respon-
sible for modulation is still unknown and could be addressed
in future experimental work.
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